Does NILOTINIB Cause Hyperbilirubinaemia? 71 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 71 reports of Hyperbilirubinaemia have been filed in association with NILOTINIB (nilotinib). This represents 0.3% of all adverse event reports for NILOTINIB.
71
Reports of Hyperbilirubinaemia with NILOTINIB
0.3%
of all NILOTINIB reports
5
Deaths
19
Hospitalizations
How Dangerous Is Hyperbilirubinaemia From NILOTINIB?
Of the 71 reports, 5 (7.0%) resulted in death, 19 (26.8%) required hospitalization, and 3 (4.2%) were considered life-threatening.
Is Hyperbilirubinaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for NILOTINIB. However, 71 reports have been filed with the FAERS database.
What Other Side Effects Does NILOTINIB Cause?
Death (2,667)
Fatigue (1,679)
Rash (1,250)
Nausea (1,180)
Headache (1,177)
Pain (1,169)
Dyspnoea (1,070)
Diarrhoea (998)
Drug ineffective (992)
Malaise (961)
What Other Drugs Cause Hyperbilirubinaemia?
METHOTREXATE (603)
RIBAVIRIN (560)
VINCRISTINE (479)
CYTARABINE (397)
PEGASPARGASE (349)
ACETAMINOPHEN (330)
CYCLOPHOSPHAMIDE (330)
DEXAMETHASONE (315)
CAPECITABINE (279)
SOFOSBUVIR (260)
Which NILOTINIB Alternatives Have Lower Hyperbilirubinaemia Risk?
NILOTINIB vs NIMESULIDE
NILOTINIB vs NIMODIPINE
NILOTINIB vs NINTEDANIB
NILOTINIB vs NINTEDANIB ESYLATE
NILOTINIB vs NIRAPARIB